Y-mAbs Therapeutics, Inc. Quarterly Operating Margin in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q3 2021 to Q2 2024.
  • Y-mAbs Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -31.9 %, a 35.2% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Operating Margin for 2023 was -30.3 %, a 79.2% increase from 2022.
  • Y-mAbs Therapeutics, Inc. annual Operating Margin for 2022 was -145 %, a 56.1% increase from 2021.
  • Y-mAbs Therapeutics, Inc. annual Operating Margin for 2021 was -331 %, a 42.8% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -31.9 +17.4 +35.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -29.7 +69.8 +70.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.3 +115 +79.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -25.4 +273 +91.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -49.3 +282 +85.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -99.5 +188 +65.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -145 +186 +56.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -298 -81.4 -37.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -332 Apr 1, 2022 Jun 30, 2022
Q1 2022 -287 Jan 1, 2022 Mar 31, 2022
Q4 2021 -331 Oct 1, 2021 Dec 31, 2021
Q3 2021 -217 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.